News & Events

PhD student Annalisa Ferrotta is conducting research at Weill Cornell Medicine to try to understand why treatments that have been effective for other cancers have not worked for glioblastoma.

PhD student Sola Olawore at UNC-Chapel Hill is studying the long-term safety of antenatal corticosteroids, a treatment given to pregnant people at imminent risk of preterm birth.

Thomas Kuret, an MD-PhD student at Thomas Jefferson University, is researching whether activating a specific protein can prevent or reverse brain cell death in Parkinson’s disease.

In this PhRMA Foundation webinar, learn about the importance of patient engagement in value assessment and health outcomes research and how applicants for PhF awards can demonstrate their commitment to patient-centered research.

Do you have questions about the PhRMA Foundation’s grants and fellowships? Join our team for an informational webinar and Q&A session about our 2026 research funding opportunities.

In this webinar, we’ll share an overview of Pfizer’s postdoc program and how to apply, and current Pfizer fellows will discuss their experiences and answer questions.

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. Fiona H. Marshall, PhD, President of Biomedical Research at Novartis, and Dr. Patrizia Cavazzoni, MD, Chief Medical Officer and Executive Vice President at Pfizer.

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. John C. Reed, MD, PhD, Executive Vice President of Innovative Medicine R&D at Johnson & Johnson (J&J), and Dr. Donatello Crocetta, MD, MBA, Chief Medical Officer and Head of Medical Communities at UCB.

The PhRMA Foundation awarded five early-career researchers with 2025 fellowships and grants in value assessment and health outcomes research.